<DOC>
	<DOCNO>NCT00263861</DOCNO>
	<brief_summary>RATIONALE : Learning side effect chemotherapy may help plan treatment may help patient live comfortably . PURPOSE : This clinical trial study nerve function old diabetic patient undergo chemotherapy metastatic solid tumor .</brief_summary>
	<brief_title>Nerve Function Older Diabetic Patients Who Are Undergoing Chemotherapy Metastatic Solid Tumors</brief_title>
	<detailed_description>OBJECTIVES : Primary - Determine change peripheral nerve function old patient diabetes metastatic solid tumor treat taxane platinum-containing chemotherapy regimen . - Determine extent age , pre-existing diabetes mellitus , level glycemic control predict differential pattern outcome beyond effect drug patient treat regimen . - Develop clinical assessment would predict whether patient diabetes mellitus less susceptible neurotoxic effect chemotherapy . OUTLINE : This longitudinal study . Patients undergo interview clinical evaluation measure demographic data , cutaneous sensation , gait balance , vibration , low extremity muscle strength , orthostatic blood pressure , glycemic control . Patients evaluated baseline , every 3 week chemotherapy 4 treatment , 2 month completion treatment . PROJECTED ACCRUAL : A total 50 patient accrue study .</detailed_description>
	<mesh_term>Neurotoxicity Syndromes</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis solid tumor Metastatic disease ( stage IV ) Planning neoadjuvant adjuvant treatment locoregional definitive systemic therapy comprise â‰¥ 1 following : Taxane ( paclitaxel docetaxel ) Platinum ( cisplatin , carboplatin , oxaliplatin ) Diagnosis type I II diabetes mellitus PATIENT CHARACTERISTICS : Performance status Not specify Life expectancy Not specify Hematopoietic Not specify Hepatic Not specify Renal Not specify Other No disease reduce peripheral nerve function ( e.g. , HIV/AIDS , uremia , spinal injury , alcoholism , CNS problem ) PRIOR CONCURRENT THERAPY : Chemotherapy See Disease Characteristics No prior chemotherapy No prior concurrent neurotoxic drug ( i.e. , vincristine )</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>neurotoxicity</keyword>
	<keyword>unspecified adult solid tumor , protocol specific</keyword>
</DOC>